Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • V vs GSK✓SelectedUSD · GSKV vs GSK performance historyLatest closeAs of+0.16%11/16
Stock and ETF performance explorer

V vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+116.0%
GSK return
+47.4%
Excess return
+68.7%
Maximum drawdown
-24.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-0.1%+0.2%+0.2%
7D+1.2%-1.3%+2.5%+1.5%
30D+6.1%+2.7%+3.4%+5.5%
3M+17.3%+2.7%+14.6%+16.5%
6M+31.4%+3.3%+28.1%+30.1%
YTD+22.6%+6.5%+16.1%+19.8%
1Y+30.2%+10.7%+19.6%+26.1%
3Y+75.5%+64.4%+11.1%+51.1%
All+116.0%+47.4%+68.7%+78.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling